Preliminary Injunction against Generic Manufacturer Allegedly Infringing BMS Patent
On November 29, 2023, the Japanese subsidiary biopharmaceutical corporation, Bristol Myers Squibb (BMS), announced that the Tokyo District Court issued a preliminary injunction order against Sawai Pharmaceutical Co., Ltd., a Japanese generic drug manufacturer, that prohibits sales and manufacture of